Main Session
Sep
28
SS 22 - Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic Malignancies
204 - Tislelizumab plus P-GemOx-14 and Radiotherapy for Early-Stage High-Risk Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial
Presenter(s)
Shunan Qi, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing